UC Irvine public health professor to lead malaria field research in Southeast Asia

NewsGuard 100/100 Score

Public health professor Guiyun Yan will lead field research

UC Irvine public health professor Guiyun Yan will lead groundbreaking malaria field research in impoverished reaches of China, Myanmar and Thailand, thanks to new federal funding. UCI will receive $4.7 million of a seven-year, $14.5 million award to Pennsylvania State University by the National Institute of Allergy & Infectious Diseases. Yan will collaborate with Penn State principal investigator Liwang Cui.

There are several strains of malaria - some increasingly drug-resistant - in Southeast Asia. Fighting the disease in hilly, strife-ridden areas is difficult. Researchers hope to gain broader results by working with transients, refugees and Chinese residents near the Myanmar border.

Transmitted by mosquito bites in tropical and subtropical zones, malaria causes fever, chills and flulike symptoms and can be deadly. About 40 percent of the world's population live in at-risk areas, with about 240 million cases resulting in 850,000 deaths annually, according to NIAID. The Penn State-UCI project is one of 10 global malaria research efforts the agency is funding.

Source: University of California - Irvine

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Innovative malaria prodrug targets liver, enhances efficacy while reducing toxicity, preclinical studies show